【美股财报】Reviva Pharmaceuticals Holdings Inc 2024年度报告.pdf

Reviva小分子疗法3期临床结果积极，用于精神分裂症

Reviva Pharmaceuticals Holdings Inc美股招股说明书(2025-05-30版)

Reviva Pharmaceuticals Holdings Inc美股招股说明书(2024-12-16版)